Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Pre-malignant extracellular matrix drives leukemia transformation through reprogramming of pre-leukemic stem cells

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAbdullah Mahmood AliMOMałgorzata OlszewskaHMHager Mansour

Discussion

Loading...

Member takes

Overview

Analysis shows pre-leukemic stem cells acquire leukemia traits through nucleoporin downregulation, highlighting leukemia progression.

Key Points

  • Leukemia transformation is driven by a reprogramming in pre-leukemic stem cells.
  • Nucleoporin downregulation correlates with disease progression in bone marrow samples.
  • Analysis utilizing RNA sequencing demonstrated altered cell cycle pathways in leukemia models.
  • Identifying extracellular matrix changes may offer new therapeutic targets for acute myeloid leukemia.

Cite This Study

Ali et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d818https://doi.org/10.1182/blood-2025-3187
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NUP98-rearranged pediatric AML is sustained by a conserved leukemia stem cell program with SPNS2/3 as a targetable vulnerability2025
  2. 2Disrupting CXCL12-DPP4-GPC3 axis redistributes leukemia stem cells and confines AML cells within bone marrow niche2025 · 1 citations
  3. 3Characterising the leukaemic microenvironment in a mouse model of infant AML with prenatal KMT2A-MLLT3 expression2025
  4. 4Spatial single-cell multiomics of the bone marrow microenvironment in NPM1-mutant Acute Myeloid Leukemia2025
  5. 5Targeting CCL3+mono like LSC overcomes chemotherapy resistance in NPM1 mutant AML2025